Rein Therapeutics Statistics

Total Valuation

RNTX has a market cap or net worth of $40.66 million. The enterprise value is $38.56 million.

Market Cap	40.66M
Enterprise Value	38.56M

Important Dates

The next estimated earnings date is Thursday, May 14, 2026, after market close.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

RNTX has 28.04 million shares outstanding. The number of shares has increased by 41.84% in one year.

Current Share Class	28.04M
Shares Outstanding	28.04M
Shares Change (YoY)	+41.84%
Shares Change (QoQ)	+11.02%
Owned by Insiders (%)	0.46%
Owned by Institutions (%)	18.24%
Float	21.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.47
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.70

Current Ratio	0.70
Quick Ratio	0.52
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -139.87% and return on invested capital (ROIC) is -38.44%.

Return on Equity (ROE)	-139.87%
Return on Assets (ROA)	-31.75%
Return on Invested Capital (ROIC)	-38.44%
Return on Capital Employed (ROCE)	-121.99%
Weighted Average Cost of Capital (WACC)	11.94%
Revenue Per Employee	n/a
Profits Per Employee	-$4.99M
Employee Count	10
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-712,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.08% in the last 52 weeks. The beta is 1.40, so RNTX's price volatility has been higher than the market average.

Beta (5Y)	1.40
52-Week Price Change	-24.08%
50-Day Moving Average	1.37
200-Day Moving Average	1.32
Relative Strength Index (RSI)	44.88
Average Volume (20 Days)	146,241

Short Selling Information

The latest short interest is 236,711, so 0.84% of the outstanding shares have been sold short.

Short Interest	236,711
Short Previous Month	487,162
Short % of Shares Out	0.84%
Short % of Float	1.10%
Short Ratio (days to cover)	1.86

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-21.93M
Pretax Income	-50.58M
Net Income	-49.87M
EBITDA	-21.93M
EBIT	-21.93M
Earnings Per Share (EPS)	-$1.96

Full Income Statement

Balance Sheet

The company has $3.22 million in cash and n/a in debt, giving a net cash position of $3.22 million or $0.11 per share.

Cash & Cash Equivalents	3.22M
Total Debt	n/a
Net Cash	3.22M
Net Cash Per Share	$0.11
Equity (Book Value)	16.92M
Book Value Per Share	-1.02
Working Capital	-1.85M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-19.36M
Capital Expenditures	n/a
Depreciation & Amortization	1,000
Net Borrowing	n/a
Free Cash Flow	-19.36M
FCF Per Share	-$0.69

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RNTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-41.84%
Shareholder Yield	-41.84%
Earnings Yield	-119.37%
FCF Yield	-46.34%

Analyst Forecast

The average price target for RNTX is $10.00, which is 589.66% higher than the current price. The consensus rating is "Buy".

Price Target	$10.00
Price Target Difference	589.66%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on November 11, 2022. It was a reverse split with a ratio of 1:20.

Last Split Date	Nov 11, 2022
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	1